XBiotech Inc
XBIT
Get informed when a big investor buys or sells
+ FollowMarket Cap$69.82M
Close$
$4.12
90.7% upside
Current Fair Value
90.7% upsideUndervalued by 90.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $69.82 Million |
|---|---|
| Enterprise Value | $-37,879,096.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.49 |
| Beta | 0.8 |
| Outstanding Shares | 30,487,731 |
Return
| Return on Equity | -35.13% |
|---|---|
| Return on Assets | -33.77% |
| Return on Invested Capital | -35.81% |
Valuation & Multiples
| P/E Ratio | -1.55 |
|---|---|
| PEG | -0.55 |
| Price to Sales | - |
| Price to Book Ratio | 0.54 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.81 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.05 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$0.03
Average shareholder expectationRevenue Estimate
$7.00 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.4207▲ 42.06% |
|---|---|
| Total Calls | 104,600▲ 395.73% |
| Total Puts | 44,000▲ Infinity% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 6.50%▼ 0.04% |
|---|---|
| Total Invested | $4.56M▼ 2.66% |
| Investors Holding | 39▲ 1.00% |
ESG Score
No data
About XBiotech Inc
CEO: John Simard